| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/26/2009 | WO2009141330A1 Method for manufacturing l-amino acids |
| 11/26/2009 | WO2009140765A1 Selective caspase inhibitors and uses thereof |
| 11/26/2009 | WO2009140763A1 Novel ghrelin analogues |
| 11/26/2009 | WO2009140724A1 Herg mutants and uses thereof |
| 11/26/2009 | WO2009140722A1 A modified galectin-2 and uses thereof |
| 11/26/2009 | WO2009115664A3 Crystalline structure of the cc2-lz domain of nemo |
| 11/26/2009 | WO2009105492A3 Transgenic plants having altered nitrogen use efficiency characteristics |
| 11/26/2009 | WO2009098196A3 Molecular targets and compounds, methods to identify the same, useful in the treatment of neurodegenerative diseases. |
| 11/26/2009 | WO2009095916A3 Cd14 and peptides thereof for protection of cells against cell death |
| 11/26/2009 | WO2009093246A3 Clusterin derived peptide |
| 11/26/2009 | WO2009090493A3 Tlr4 decoy receptor protein |
| 11/26/2009 | WO2009079399A3 Method of treating neurodegenerative disease |
| 11/26/2009 | WO2009068588A8 Transgenic plants with increased stress tolerance and yield |
| 11/26/2009 | WO2009066180A3 Method for the separation of cells |
| 11/26/2009 | WO2008115525A9 Metal-binding therapeutic peptides |
| 11/26/2009 | WO2008113145A8 Proteins from the webs of nephilengys cruentata, avicularia juruensis and parawixia bistriata spiders |
| 11/26/2009 | WO2008108830A8 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 11/26/2009 | US20090293154 Isolated Polypeptides, Polynucleotides Encoding Same, Transgenic Plants Expressing Same and Methods of Using Same |
| 11/26/2009 | US20090293146 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield |
| 11/26/2009 | US20090293145 Acyl-coa-dependent diacylglycerol acyltransferas 1 (dgat1) gene from tropaeolum majus, protein encoded thereby and uses thereof |
| 11/26/2009 | US20090293142 Methods for increasing shoot-to-root ratio, seed production and resistance to diseases |
| 11/26/2009 | US20090292114 Method for the purification of alpha-1-antitrypsin |
| 11/26/2009 | US20090292113 Recombinant soluble Fc receptors |
| 11/26/2009 | US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity |
| 11/26/2009 | US20090292111 ROR-alpha Promoting the Induction of Bmall |
| 11/26/2009 | US20090292108 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 11/26/2009 | US20090292107 Composition and method to alter lean body mass and bone properties in a subject |
| 11/26/2009 | US20090292106 Synthesis of glucagon-like peptide |
| 11/26/2009 | US20090292007 Inhibition of TACE or amphiregulin for the Modulation of EGF Receptor Signal Transactivation |
| 11/26/2009 | US20090292003 Cell penetrating peptides for intracellular delivery of molecules |
| 11/26/2009 | US20090291896 Genes encoding novel proteins with pesticidal activity against coleopterans |
| 11/26/2009 | US20090291892 SlpA as a tool for recombinant protein and enzyme technology |
| 11/26/2009 | US20090291891 VEGF variant that lacks VEGFR-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis |
| 11/26/2009 | US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 11/26/2009 | US20090291879 Modulation of cartilage homeostasis by active domains of cell binding extracelular matrix molecules |
| 11/26/2009 | US20090291503 Recombinant Adeno-Associated Virus Production |
| 11/26/2009 | US20090291474 Collagen-like polypeptides and encoding polynucleotides |
| 11/26/2009 | US20090291472 Influenza nucleic acids, polypeptides, and uses thereof |
| 11/26/2009 | US20090291471 Novel Beta-Galactoside Alpha 2,6-Sialyltransferase, Gene Coding For The Transferase And Process For Producing The Same |
| 11/26/2009 | US20090291460 Assay for transmissible spongiform encephalopathies |
| 11/26/2009 | US20090291450 Caterpiller gene family |
| 11/26/2009 | US20090291441 Polypeptide, nucleic acid molecule encoding it and their uses |
| 11/26/2009 | US20090291189 Highly concentrated plant protein preparation and method for producing the same |
| 11/26/2009 | US20090291100 Therapeutic agent for polycystic ovary syndrome (pcos) |
| 11/26/2009 | US20090291097 IL-17 homologous polypeptides and therapeutic uses thereof |
| 11/26/2009 | US20090291083 Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same |
| 11/26/2009 | US20090291070 Biologically Active Silver-Coated Proteins |
| 11/26/2009 | DE102008025008A1 Insulin analogs which comprise A chain and B chain with disulfide bonds for use in treatment of diabetes |
| 11/26/2009 | DE102008025007A1 Insulin analogs which comprise A chain and B chain with disulfide bonds for use in treatment of diabetes and for cartilage regeneration |
| 11/26/2009 | CA2725198A1 Novel soluble cd83 polypeptides, formulations and methods of use |
| 11/26/2009 | CA2725154A1 Methods of treatment utilizing binding proteins of the interleukin-21 receptor |
| 11/26/2009 | CA2725144A1 Method for evaluation of function of phagocyte |
| 11/26/2009 | CA2724982A1 Histamine binding protein |
| 11/26/2009 | CA2724976A1 Novel ghrelin analogues |
| 11/26/2009 | CA2724915A1 Interleukin-21 receptor binding proteins |
| 11/26/2009 | CA2724785A1 Selective caspase inhibitors and uses thereof |
| 11/26/2009 | CA2724780A1 Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm |
| 11/26/2009 | CA2724717A1 Methods, devices, kits and compositions for detecting roundworm |
| 11/26/2009 | CA2724700A1 Herg mutants and uses thereof |
| 11/26/2009 | CA2724569A1 Compositions and methods to protect cells by blocking entry of pathogen proteins |
| 11/26/2009 | CA2724545A1 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny |
| 11/26/2009 | CA2698582A1 Peptide having an extending action for half-life of object peptide in plasma |
| 11/26/2009 | CA2667177A1 Slpa as a tool for recombinant protein and enzyme technology |
| 11/25/2009 | EP2123772A1 Beta-lactam antibiotic producing strains |
| 11/25/2009 | EP2123755A1 Attenuated minus-stranded rna virus |
| 11/25/2009 | EP2123754A1 CHIMERIC Fc RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR |
| 11/25/2009 | EP2123751A1 Novel peptide |
| 11/25/2009 | EP2123680A1 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |
| 11/25/2009 | EP2123675A2 Human EPO mimentic hinge core mimetibodies, compositions, methods and uses |
| 11/25/2009 | EP2123674A1 Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor |
| 11/25/2009 | EP2123673A1 Neuronal exocytosis inhibiting peptides |
| 11/25/2009 | EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses |
| 11/25/2009 | EP2123671A1 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease |
| 11/25/2009 | EP2123670A1 Anticoagulant polypeptide |
| 11/25/2009 | EP2123669A1 Copolymers for suppression of autoimmune diseases, and methods of use |
| 11/25/2009 | EP2123668A1 Immunogenic polypeptides that mimic the surface polysaccharide O-antigen from serotype 2A shigella flexneri, method for obtaining the same, and their use in vaccine and diagnostic compositions |
| 11/25/2009 | EP2123666A1 Peptide |
| 11/25/2009 | EP2123293A2 Peptide YY and petide YY agonists for treatment of metabolic disorders |
| 11/25/2009 | EP2122359A2 Proteins |
| 11/25/2009 | EP2121958A1 Microbial process for production of enzymes |
| 11/25/2009 | EP2121935A1 Transcriptional repressors of cytokinin signaling and their use |
| 11/25/2009 | EP2121931A1 Purification of fc-tact fusion proteins using the oilbody technology |
| 11/25/2009 | EP2121930A1 Neurotrophic peptides |
| 11/25/2009 | EP2121919A2 Mutant g-protein coupled receptors and methods for selecting them |
| 11/25/2009 | EP2121764A1 Viral polyhedra complexes and methods of use |
| 11/25/2009 | EP2121761A1 He4 monoclonal antibodies and methods for their use |
| 11/25/2009 | EP2121753A2 Method of isolating antibodies by precipitation |
| 11/25/2009 | EP2121749A1 Recombinant gelatins |
| 11/25/2009 | EP2121748A2 Nucleic acid, polypeptide and its use |
| 11/25/2009 | EP2121747A2 New protein isoforms and uses thereof |
| 11/25/2009 | EP2121746A2 Potent and selective mediators of cholesterol efflux |
| 11/25/2009 | EP2121745A2 Proteins |
| 11/25/2009 | EP2121744A1 Transglutaminase variants with improved specificity |
| 11/25/2009 | EP2121743A2 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| 11/25/2009 | EP2121742A2 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 11/25/2009 | EP2121741A1 Detection of individual t-cell reaction patterns against tumor-associated antigens (taa) in tumor patients as a basis for the individual therapeutic vaccination of patients |
| 11/25/2009 | EP2121740A2 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins |
| 11/25/2009 | EP2121739A1 Novel polypeptide having anti-tumor activity |
| 11/25/2009 | EP2121738A2 Proteins |
| 11/25/2009 | EP2121737A2 Delta-8 desaturases and their use in making polyunsaturated fatty acids |